Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01311128 · ClinicalTrials.gov registry record
Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device
A clinical trial, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- 31
- Enrollment target
NCT01311128: Clinical Trial study, sponsored by Oregon Health and Science University.
NCT01311128 is a clinical trial that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01311128 was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This protocol will test a new non-invasive device, the T-line, in continuously determining heart rate and blood pressure in operative and critically ill patients. The accuracy of the device will be compared to the standard radial artery catheter, as well as to the non-invasive blood pressure cuff. The T-line will also be compared to the right heart catheter determining cardiac output in at least 20 patients. Hypothesis: the T-line device will determine blood pressure and heart rate as accurately as a standard radial arterial catheter and a blood pressure cuff in perioperative patients.
Interventions
- DEVICE T-line hemodynamic monitoring device (placement and use)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-02-16 |
| Est. Completion | 2014-12-30 |
Why NCT01311128 stopped before completion
NCT01311128 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which T-line hemodynamic monitoring device (placement and use) is the first listed.
NCT01311128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01311128 about?
NCT01311128 is a clinical study titled "Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device". This protocol will test a new non-invasive device, the T-line, in continuously determining heart rate and blood pressure in operative and critically ill patients. The accuracy of the device will be compared to the standard radial artery catheter, as well as to the non-invasive blood pressure cuff. T...
What is the current status of trial NCT01311128?
This trial is currently terminated. The enrollment target is 31 participants. The study started on 2011-02-16. Estimated completion is 2014-12-30.
What interventions are being tested in trial NCT01311128?
The interventions under investigation include: T-line hemodynamic monitoring device (placement and use) (DEVICE).
Who is sponsoring clinical trial NCT01311128?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI